Inovio Pharmaceuticals Inc (INO)

[Lakers_w]

12/16 DNA ENCODED ANTIBODIES FOR USE AGAINST SARS-COV-2 Patent
Title
(EN) DNA ENCODED ANTIBODIES FOR USE AGAINST SARS-COV-2
(FR) ANTICORPS CODÉS PAR ADN DESTINÉS À ÊTRE UTILISÉS CONTRE LE SARS-COV-2
Abstract
(EN) Disclosed herein are antibodies to SARS-CoV-2 antigens and recombinant nucleic acid sequences that encode the SARS-CoV-2 antibodies. The disclosure also provides a method of preventing and/or treating a SARS-CoV-2 infection or disease or disorder associated with SARS-CoV-2 infection (e.g., COVID-19) in a subject using said compositions and methods.

Publication Number
WO/2021/252620
Publication Date
16.12.2021
International Application No.
PCT/US2021/036606
International Filing Date
09.06.2021
IPC
C07K 16/10 2006.1
Applicants
THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY [US]/[US]
WEINER, David [US]/[US]
MUTHUMANI, Kar [US]/[US]
PARZYCH, Elizabeth [US]/[US]
Inventors
WEINER, David
MUTHUMANI, Kar
PARZYCH, Elizabeth
Agents
FONVILLE, Natalie, C.
ARTIS, Ryan
ALLEN, Justin
ALLEN, Scott
BUNN, Andrew
Priority Data
63/036,795 09.06.2020 US
63/036,809 09.06.2020 US
63/068,868 21.08.2020 US
63/083,173 25.09.2020 US
63/114,271 16.11.2020 US
Publication Language
English (en)
Filing Language
English (EN)
Designated States
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021252620&_cid=P22-KX93ZP-37534-1